These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 26864554)

  • 1. Phytochemicals for the Management of Melanoma.
    Pal HC; Hunt KM; Diamond A; Elmets CA; Afaq F
    Mini Rev Med Chem; 2016; 16(12):953-79. PubMed ID: 26864554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
    Kundu A; Quirit JG; Khouri MG; Firestone GL
    Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging phytochemicals for prevention of melanoma invasion.
    Jones V; Katiyar SK
    Cancer Lett; 2013 Jul; 335(2):251-8. PubMed ID: 23474498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Anticancer Activities of Natural Terpenoids That Inhibit Both Melanoma and Non-Melanoma Skin Cancers.
    Yoon YE; Jung YJ; Lee SJ
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances on Natural Polyphenols as Anticancer Agents for Skin Cancer.
    Sajadimajd S; Bahramsoltani R; Iranpanah A; Kumar Patra J; Das G; Gouda S; Rahimi R; Rezaeiamiri E; Cao H; Giampieri F; Battino M; Tundis R; Campos MG; Farzaei MH; Xiao J
    Pharmacol Res; 2020 Jan; 151():104584. PubMed ID: 31809853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.
    Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X
    Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting drivers of melanoma with synthetic small molecules and phytochemicals.
    Strickland LR; Pal HC; Elmets CA; Afaq F
    Cancer Lett; 2015 Apr; 359(1):20-35. PubMed ID: 25597784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.
    Momtaz S; Niaz K; Maqbool F; Abdollahi M; Rastrelli L; Nabavi SM
    Biofactors; 2017 May; 43(3):347-370. PubMed ID: 27896891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells.
    Fratangelo F; Camerlingo R; Carriero MV; Pirozzi G; Palmieri G; Gentilcore G; Ragone C; Minopoli M; Ascierto PA; Motti ML
    Int J Oncol; 2018 Sep; 53(3):1149-1159. PubMed ID: 29956724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.
    Dandawate PR; Subramaniam D; Jensen RA; Anant S
    Semin Cancer Biol; 2016 Oct; 40-41():192-208. PubMed ID: 27609747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 22β-hydroxytingenone induces apoptosis and suppresses invasiveness of melanoma cells by inhibiting MMP-9 activity and MAPK signaling.
    Aranha ESP; Portilho AJS; Bentes de Sousa L; da Silva EL; Mesquita FP; Rocha WC; Araújo da Silva FM; Lima ES; Alves APNN; Koolen HHF; Montenegro RC; Vasconcellos MC
    J Ethnopharmacol; 2021 Mar; 267():113605. PubMed ID: 33232779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galangin inhibits tumor growth and metastasis of B16F10 melanoma.
    Zhang W; Tang B; Huang Q; Hua Z
    J Cell Biochem; 2013 Jan; 114(1):152-61. PubMed ID: 22887049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling metastatic cancer: the role of phytochemicals in cell signaling.
    Kapinova A; Kubatka P; Liskova A; Baranenko D; Kruzliak P; Matta M; Büsselberg D; Malicherova B; Zulli A; Kwon TK; Jezkova E; Blahutova D; Zubor P; Danko J
    J Cancer Res Clin Oncol; 2019 May; 145(5):1087-1109. PubMed ID: 30903319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Compounds in the Chemoprevention of Malignant Melanoma.
    Danciu C; Soica C; Antal D; Alexa E; Pavel IZ; Ghiulai R; Ardelean F; Babuta RM; Popescu A; Dehelean CA
    Anticancer Agents Med Chem; 2018; 18(5):631-644. PubMed ID: 29173184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of proliferation and invasion in 2D and 3D models by 2-methoxyestradiol in human melanoma cells.
    Massaro RR; Faião-Flores F; Rebecca VW; Sandri S; Alves-Fernandes DK; Pennacchi PC; Smalley KSM; Maria-Engler SS
    Pharmacol Res; 2017 May; 119():242-250. PubMed ID: 28212889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.
    Gowda R; Sharma A; Robertson GP
    Cancer Lett; 2017 Jan; 385():243-250. PubMed ID: 27769779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer.
    Budisan L; Gulei D; Zanoaga OM; Irimie AI; Sergiu C; Braicu C; Gherman CD; Berindan-Neagoe I
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary phytochemicals in the regulation of epithelial to mesenchymal transition and associated enzymes: A promising anticancer therapeutic approach.
    Das B; Sarkar N; Bishayee A; Sinha D
    Semin Cancer Biol; 2019 Jun; 56():196-218. PubMed ID: 30472212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor‒Resistant Melanoma.
    Zhang C; Smalley I; Emmons MF; Sharma R; Izumi V; Messina J; Koomen JM; Pasquale EB; Forsyth PA; Smalley KSM
    J Invest Dermatol; 2021 Apr; 141(4):840-851.e4. PubMed ID: 32890629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
    Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
    Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.